Riddhi Siddhi Gl (524480)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Stock trades at a 74% discount to book value (P/B 0.26), offering a deep-value asset cushion.
• Market cap of ₹457 Cr is far below the implied book value of roughly ₹1,758 Cr (₹2,465.25 per share), leaving room for value unlock if assets are worth stated values.
• Reported P/E of 12.97 is not expensive, assuming earnings stabilize and the latest quarterly loss does not persist.
• Latest quarter revenue of ₹40 Cr shows an ongoing operating entity, not an empty shell.

Concerns

• Profit growth of -99.29% and a latest quarter net loss of ₹1 Cr show that earnings power has collapsed.
• ROE of 3.59% and ROCE of 4.88% are far below acceptable return thresholds, undermining the quality of the asset base.
• Sales declined 9.59%, indicating shrinking demand or pricing pressure.
• Piotroski F-score of 3/9 points to weak financial health and possible balance-sheet deterioration.

AI Analysis

When I look at Riddhi Siddhi Gl, I see a business that Graham might call a bargain on the surface, but Buffett would demand proof before acting. The price is ₹640.85, while book value stands at ₹2,465.25. That means the market is valuing every rupee of net assets at just 26 paise. A price-to-book of 0.26 is not something you see every day. However, a low multiple on assets is only attractive if those assets earn a decent return. Here, ROE is 3.59% and ROCE is 4.88%. That is far below the returns I expect from a quality enterprise. Sales have declined 9.59%, profit growth has collapsed by 99.29%, and the latest quarter shows ₹40 crore of sales with a ₹1 crore loss. The Piotroski F-score of 3/9 reinforces my concern: the company's financial health is weak and deteriorating. A reported P/E of 12.97 is of little use when earnings have vanished and the last quarter is in the red. The dividend yield of 0.61% provides hardly any compensation while I wait. So is this an asset play or a value trap? I cannot say yet. The deep discount to book value creates a potential margin of safety, but only if management can unlock value by improving operations, selling underperforming assets, or returning capital to shareholders. Without that, low ROE and declining sales will keep eating at the asset base. As Graham said, price is what you pay, value is what you get. Right now, the market is voting against this business. I would need evidence of a turnaround: stable or growing sales, a return to meaningful profit, and better return on capital. Until then, this remains a classic asset play with serious operating concerns, not a compounder.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer